Edwards Lifesciences Gross Margin 2010-2023 | EW
Current and historical gross margin for Edwards Lifesciences (EW) over the last 10 years. The current gross profit margin for Edwards Lifesciences as of December 31, 2023 is %.
| Edwards Lifesciences Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2023-12-31 | $6.01B | $4.63B | 77.02% |
| 2023-09-30 | $5.82B | $4.54B | 77.99% |
| 2023-06-30 | $5.66B | $4.47B | 79.05% |
| 2023-03-31 | $5.50B | $4.39B | 79.80% |
| 2022-12-31 | $5.38B | $4.30B | 79.93% |
| 2022-09-30 | $5.36B | $4.23B | 78.90% |
| 2022-06-30 | $5.36B | $4.17B | 77.78% |
| 2022-03-31 | $5.36B | $4.10B | 76.57% |
| 2021-12-31 | $5.23B | $3.98B | 76.11% |
| 2021-09-30 | $5.10B | $3.86B | 75.72% |
| 2021-06-30 | $4.93B | $3.72B | 75.52% |
| 2021-03-31 | $4.48B | $3.37B | 75.20% |
| 2020-12-31 | $4.39B | $3.31B | 75.36% |
| 2020-09-30 | $4.37B | $3.30B | 75.51% |
| 2020-06-30 | $4.32B | $3.24B | 74.99% |
| 2020-03-31 | $4.48B | $3.34B | 74.42% |
| 2019-12-31 | $4.35B | $3.23B | 74.38% |
| 2019-09-30 | $4.15B | $3.09B | 74.40% |
| 2019-06-30 | $3.97B | $2.97B | 74.88% |
| 2019-03-31 | $3.82B | $2.88B | 75.46% |
| 2018-12-31 | $3.72B | $2.78B | 74.76% |
| 2018-09-30 | $3.64B | $2.69B | 74.11% |
| 2018-06-30 | $3.55B | $2.62B | 73.80% |
| 2018-03-31 | $3.45B | $2.55B | 74.04% |
| 2017-12-31 | $3.44B | $2.56B | 74.48% |
| 2017-09-30 | $3.32B | $2.46B | 74.22% |
| 2017-06-30 | $3.23B | $2.39B | 73.96% |
| 2017-03-31 | $3.15B | $2.32B | 73.56% |
| 2016-12-31 | $2.96B | $2.17B | 73.10% |
| 2016-09-30 | $2.87B | $2.11B | 73.52% |
| 2016-06-30 | $2.74B | $2.04B | 74.30% |
| 2016-03-31 | $2.60B | $1.94B | 74.55% |
| 2015-12-31 | $2.49B | $1.88B | 75.22% |
| 2015-09-30 | $2.44B | $1.84B | 75.34% |
| 2015-06-30 | $2.43B | $1.81B | 74.38% |
| 2015-03-31 | $2.39B | $1.78B | 74.27% |
| 2014-12-31 | $2.32B | $1.70B | 73.13% |
| 2014-09-30 | $2.24B | $1.63B | 72.86% |
| 2014-06-30 | $2.13B | $1.56B | 73.27% |
| 2014-03-31 | $2.07B | $1.53B | 73.88% |
| 2013-12-31 | $2.05B | $1.53B | 74.73% |
| 2013-09-30 | $2.02B | $1.53B | 75.50% |
| 2013-06-30 | $1.97B | $1.49B | 75.76% |
| 2013-03-31 | $1.94B | $1.45B | 74.96% |
| 2012-12-31 | $1.90B | $1.41B | 74.14% |
| 2012-09-30 | $1.82B | $1.33B | 73.17% |
| 2012-06-30 | $1.78B | $1.28B | 71.86% |
| 2012-03-31 | $1.73B | $1.23B | 71.15% |
| 2011-12-31 | $1.68B | $1.19B | 70.82% |
| 2011-09-30 | $1.64B | $1.16B | 70.51% |
| 2011-06-30 | $1.58B | $1.12B | 71.21% |
| 2011-03-31 | $1.51B | $1.09B | 71.81% |
| 2010-12-31 | $1.45B | $1.04B | 71.80% |
| 2010-09-30 | $1.40B | $1.01B | 71.68% |
| 2010-06-30 | $1.38B | $0.98B | 70.99% |
| 2010-03-31 | $1.35B | $0.95B | 70.22% |
| 2009-12-31 | $1.32B | $0.92B | 69.77% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $51.257B | $6.005B |
| Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.054B | 26.42 |
| Intuitive Surgical (ISRG) | United States | $133.955B | 80.69 |
| DexCom (DXCM) | United States | $50.367B | 76.29 |
| IQVIA Holdings (IQV) | United States | $40.318B | 23.48 |
| IDEXX Laboratories (IDXX) | United States | $39.297B | 46.06 |
| Alcon (ALC) | Switzerland | $38.669B | 28.52 |
| STERIS (STE) | Ireland | $20.379B | 24.12 |
| Waters (WAT) | United States | $18.717B | 26.86 |
| Hologic (HOLX) | United States | $17.818B | 19.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.032B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.711B | 15.70 |
| ShockWave Medical (SWAV) | United States | $12.378B | 85.27 |
| Sysmex ADR (SSMXY) | Japan | $10.769B | 33.77 |
| Teleflex (TFX) | United States | $9.360B | 14.57 |
| Penumbra (PEN) | United States | $7.986B | 98.59 |
| Masimo (MASI) | United States | $7.209B | 40.43 |
| Globus Medical (GMED) | United States | $6.834B | 21.67 |
| Glaukos (GKOS) | United States | $5.271B | 0.00 |
| TransMedics (TMDX) | United States | $4.071B | 388.88 |
| Integer Holdings (ITGR) | United States | $3.683B | 22.25 |
| LivaNova (LIVN) | United Kingdom | $3.407B | 20.23 |
| PROCEPT BioRobotics (PRCT) | United States | $3.173B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.695B | 18.49 |
| Nihon Kohden (NHNKY) | Japan | $2.459B | 20.80 |
| Inari Medical (NARI) | United States | $2.441B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.360B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.260B | 9.27 |
| RxSight (RXST) | United States | $2.206B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.847B | 0.00 |
| Veracyte (VCYT) | United States | $1.543B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.911B | 18.08 |
| OPKO Health (OPK) | United States | $0.906B | 0.00 |
| Artivion (AORT) | United States | $0.847B | 97.86 |
| Paragon 28 (FNA) | United States | $0.810B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.757B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.745B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.661B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.612B | 20.76 |
| SiBone (SIBN) | United States | $0.602B | 0.00 |
| IRadimed (IRMD) | United States | $0.555B | 31.10 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.495B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.479B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.445B | 0.00 |
| Nevro (NVRO) | United States | $0.409B | 0.00 |
| NeuroPace (NPCE) | United States | $0.399B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.343B | 11.55 |
| Sight Sciences (SGHT) | United States | $0.278B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.272B | 0.00 |
| AxoGen (AXGN) | United States | $0.257B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.244B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.187B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.186B | 10.05 |
| CVRx (CVRX) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.166B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.164B | 0.00 |
| Accuray (ARAY) | United States | $0.153B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.151B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.149B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.109B | 0.00 |
| Neuronetics (STIM) | United States | $0.105B | 0.00 |
| Envoy Medical (COCH) | United States | $0.095B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.095B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 128.67 |
| Autonomix Medical (AMIX) | United States | $0.061B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.059B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.059B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| InspireMD (NSPR) | Israel | $0.047B | 0.00 |
| DarioHealth (DRIO) | United States | $0.045B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.042B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.041B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.037B | 0.00 |
| LENSAR (LNSR) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Spectral AI (MDAI) | United States | $0.030B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.025B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| PAVmed (PAVM) | United States | $0.021B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.020B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |